Analysed INSMED INC (INSM:NASDAQ) News Sources
FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027
21-09-2026
yahoo.com
Did FDA Priority Review of ARIKAYCE ENCORE Data Just Shift Insmed's (INSM) Investment Narrative?
21-09-2026
yahoo.com
What is the current price of INSMED INC (INSM:NASDAQ)?
The current price of INSMED INC (INSM:NASDAQ) is $100.6.
INSMED INC (INSM:NASDAQ) absolute price change since previous trading day?
The absolute price change of INSMED INC (INSM:NASDAQ) since the previous trading day is $0.12.
INSMED INC (INSM:NASDAQ) percentage price change since previous trading day?
The percentage price change of INSMED INC (INSM:NASDAQ) since the previous trading day is 0.1194%.
What is the most recent average sentiment score for INSMED INC (INSM:NASDAQ)?
The most recent average sentiment score for INSMED INC (INSM:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for INSMED INC (INSM:NASDAQ)?
The most recent sentiment for INSMED INC (INSM:NASDAQ) is .
SEC-8K** Filing Available For INSMED INC (INSM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.